Posts in tag
Reuters Health
Expert panel updates advice on BRCA cancer gene screening
(Reuters Health) – Mutations in the BRCA1 and BRCA2 genes are associated with increased risks for breast, ovarian, and other cancers, but only certain women stand to benefit from genetic testing, according to updated recommendations from the U.S. Preventive Services Task Force (USPSTF). “Whether or not the harms of risk assessment, counseling, testing, and interventions …
